Findings from a study on the utility of ultrasensitive circulating tumor DNA (ctDNA) as a predictive biomarker for patients with advanced solid tumors undergoing immunotherapy show that whole-genome sequencing (WGS)-based ctDNA assay offered…
ctDNA Assay Offers Prognostic Insights for Immunotherapy-Treated Solid Tumors | Targeted Oncology
